Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort

Objectives: The aim of this study was to evaluate the impact on 30-day mortality of early use of corticosteroids in COVID-19 patients with supplementary oxygen requirements and without invasive mechanical ventilation at the initiation of therapy. Methods: All patients hospitalized with COVID-19 betw...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	A. Moreno, C. Vargas, F. Azocar, F. Villarroel, M. Cofré, H. Oppliger, F. Ríos, M. Raijmakers, I. Silva-Ayarza, C. Beltrán, F. Zamora
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Chile COVID-19 Latin America mortality propensity score steroids Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/19290fb3c904465b906f46b56be3c7dd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:19290fb3c904465b906f46b56be3c7dd
record_format	dspace
spelling	oai:doaj.org-article:19290fb3c904465b906f46b56be3c7dd2021-11-30T04:14:19ZSteroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort1201-971210.1016/j.ijid.2021.09.038https://doaj.org/article/19290fb3c904465b906f46b56be3c7dd2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221007451https://doaj.org/toc/1201-9712Objectives: The aim of this study was to evaluate the impact on 30-day mortality of early use of corticosteroids in COVID-19 patients with supplementary oxygen requirements and without invasive mechanical ventilation at the initiation of therapy. Methods: All patients hospitalized with COVID-19 between April 15 and July 15, 2020, and requiring supplementary oxygen, were prospectively included in a database. Patients who died or required intubation within the first 48 hours were excluded. Patients who received corticosteroids within the first 5 days of hospitalization and at least 24 hours prior to intubation were allocated to the ‘early corticosteroids’ group. To compare both populations and adjust for non-random treatment assignment bias, a weight-adjusted propensity score model was used. Results: In total, 571 patients met the inclusion criteria, 520 had sufficient information for the analysis. Of these, 233 received early corticosteroids and 287 did not. Analysis showed a reduction of 8.5% (p = 0.038) in 30-day mortality in the early corticosteroid group. The reduction in mortality was not significant when patients with corticosteroid initiation between day 5 and day 8 of hospitalization were included. Conclusion: Early corticosteroid use reduced mortality in patients with pneumonia due to COVID-19, who required supplementary oxygen but not initial invasive mechanical ventilation.A. MorenoC. VargasF. AzocarF. VillarroelM. CofréH. OppligerF. RíosM. RaijmakersI. Silva-AyarzaC. BeltránF. ZamoraElsevierarticleChileCOVID-19Latin Americamortalitypropensity scoresteroidsInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 112, Iss , Pp 124-129 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Chile COVID-19 Latin America mortality propensity score steroids Infectious and parasitic diseases RC109-216
spellingShingle	Chile COVID-19 Latin America mortality propensity score steroids Infectious and parasitic diseases RC109-216 A. Moreno C. Vargas F. Azocar F. Villarroel M. Cofré H. Oppliger F. Ríos M. Raijmakers I. Silva-Ayarza C. Beltrán F. Zamora Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort
description	Objectives: The aim of this study was to evaluate the impact on 30-day mortality of early use of corticosteroids in COVID-19 patients with supplementary oxygen requirements and without invasive mechanical ventilation at the initiation of therapy. Methods: All patients hospitalized with COVID-19 between April 15 and July 15, 2020, and requiring supplementary oxygen, were prospectively included in a database. Patients who died or required intubation within the first 48 hours were excluded. Patients who received corticosteroids within the first 5 days of hospitalization and at least 24 hours prior to intubation were allocated to the ‘early corticosteroids’ group. To compare both populations and adjust for non-random treatment assignment bias, a weight-adjusted propensity score model was used. Results: In total, 571 patients met the inclusion criteria, 520 had sufficient information for the analysis. Of these, 233 received early corticosteroids and 287 did not. Analysis showed a reduction of 8.5% (p = 0.038) in 30-day mortality in the early corticosteroid group. The reduction in mortality was not significant when patients with corticosteroid initiation between day 5 and day 8 of hospitalization were included. Conclusion: Early corticosteroid use reduced mortality in patients with pneumonia due to COVID-19, who required supplementary oxygen but not initial invasive mechanical ventilation.
format	article
author	A. Moreno C. Vargas F. Azocar F. Villarroel M. Cofré H. Oppliger F. Ríos M. Raijmakers I. Silva-Ayarza C. Beltrán F. Zamora
author_facet	A. Moreno C. Vargas F. Azocar F. Villarroel M. Cofré H. Oppliger F. Ríos M. Raijmakers I. Silva-Ayarza C. Beltrán F. Zamora
author_sort	A. Moreno
title	Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort
title_short	Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort
title_full	Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort
title_fullStr	Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort
title_full_unstemmed	Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort
title_sort	steroids and mortality in non‐critically ill covid‐19 patients: a propensity score‐weighted study in a chilean cohort
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/19290fb3c904465b906f46b56be3c7dd
work_keys_str_mv	AT amoreno steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT cvargas steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT fazocar steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT fvillarroel steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT mcofre steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT hoppliger steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT frios steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT mraijmakers steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT isilvaayarza steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT cbeltran steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort AT fzamora steroidsandmortalityinnoncriticallyillcovid19patientsapropensityscoreweightedstudyinachileancohort
_version_	1718406788549705728

Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort

Ejemplares similares